{"count":6,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/5aa32007-d489-4a50-a052-40e97a76afaa/","filing_uuid":"5aa32007-d489-4a50-a052-40e97a76afaa","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/5aa32007-d489-4a50-a052-40e97a76afaa/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"TROY ZIMMERMAN","dt_posted":"2026-04-16T21:18:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1634 Eye Street, NW","registrant_address_2":"Suite 1050","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":28105,"url":"https://lda.gov/api/v1/registrants/28105/","house_registrant_id":30683,"name":"NATIONAL KIDNEY FOUNDATION","description":null,"address_1":"1634 Eye Street, NW","address_2":"Suite 1050","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TROY ZIMMERMAN","contact_telephone":"+1 703-431-2218","dt_updated":"2026-07-09T11:52:41.712470-04:00"},"client":{"id":134490,"url":"https://lda.gov/api/v1/clients/134490/","client_id":12,"name":"NATIONAL KIDNEY FOUNDATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2026 and FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 and FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 and FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 and FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 and FY 2027 Appropriations for Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, \"Securing the U.S. Organ Procurement and Transplantation Network Act.\" Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138199,"prefix":"ms","prefix_display":"MS.","first_name":"MIRIAM","nickname":null,"middle_name":"ELIZABETH","last_name":"GODWIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, \"Treat and Reduce Obesity Act,\" to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138199,"prefix":"ms","prefix_display":"MS.","first_name":"MIRIAM","nickname":null,"middle_name":"ELIZABETH","last_name":"GODWIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/33dbca37-c558-429c-8340-5af04be0d43a/","filing_uuid":"33dbca37-c558-429c-8340-5af04be0d43a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/33dbca37-c558-429c-8340-5af04be0d43a/print/","filing_document_content_type":"text/html","income":null,"expenses":"230000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Deborah Darcy","dt_posted":"2026-04-20T17:24:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11921 Rockville Pike","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401103906,"url":"https://lda.gov/api/v1/registrants/401103906/","house_registrant_id":null,"name":"AMERICAN KIDNEY FUND","description":"Not-for-profit, charitable organization.","address_1":"11921 Rockville Pike","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DEBORAH DARCY","contact_telephone":"+1 202-560-4883","dt_updated":"2026-07-28T11:53:15.293997-04:00"},"client":{"id":200362,"url":"https://lda.gov/api/v1/clients/200362/","client_id":12,"name":"AMERICAN KIDNEY FUND","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-11-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Genetic Counselor Services Act Living Donor Protection Act: H.R. 4582; H.R 4583; S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Enhanced Advance Premium Tax Credits (eAPTCs) Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 1 CMS-1830-P: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model Proposed Local Coverage Determination (LCD) MolDX: Molecular Testing for Solid Organ Allograft Rejection Proposed LCD ID: DL40060 Proposed Local Coverage Determination (LCD) MolDX: Molecular Testing for Solid Organ Allograft Rejection Proposed LCD ID: DL40058","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63250,"prefix":null,"prefix_display":null,"first_name":"DEBORAH","nickname":null,"middle_name":null,"last_name":"DARCY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69036,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"A.","last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/616c194e-ab74-4abf-916b-486d2381a6ca/","filing_uuid":"616c194e-ab74-4abf-916b-486d2381a6ca","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/616c194e-ab74-4abf-916b-486d2381a6ca/print/","filing_document_content_type":"text/html","income":null,"expenses":"80000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"TROY ZIMMERMAN","dt_posted":"2026-07-09T12:21:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1634 Eye Street, NW","registrant_address_2":"Suite 1050","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":28105,"url":"https://lda.gov/api/v1/registrants/28105/","house_registrant_id":30683,"name":"NATIONAL KIDNEY FOUNDATION","description":null,"address_1":"1634 Eye Street, NW","address_2":"Suite 1050","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TROY ZIMMERMAN","contact_telephone":"+1 703-431-2218","dt_updated":"2026-07-09T11:52:41.712470-04:00"},"client":{"id":134490,"url":"https://lda.gov/api/v1/clients/134490/","client_id":12,"name":"NATIONAL KIDNEY FOUNDATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2027 Appropriations for Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, \"Securing the U.S. Organ Procurement and Transplantation Network Act.\" Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138199,"prefix":"ms","prefix_display":"MS.","first_name":"MIRIAM","nickname":null,"middle_name":"ELIZABETH","last_name":"GODWIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Initiatives to expand access to home dialysis. H.R. 9509, the \"Kidney Disease Education Access Expansion Act of 2026,\" to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, \"Treat and Reduce Obesity Act,\" to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10618,"prefix":null,"prefix_display":null,"first_name":"TROY","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":76169,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"DREW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138199,"prefix":"ms","prefix_display":"MS.","first_name":"MIRIAM","nickname":null,"middle_name":"ELIZABETH","last_name":"GODWIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1e4af304-f86a-4731-8dcb-f0f00d17cb82/","filing_uuid":"1e4af304-f86a-4731-8dcb-f0f00d17cb82","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1e4af304-f86a-4731-8dcb-f0f00d17cb82/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rachel N. Meyer","dt_posted":"2026-07-16T12:56:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 H Street, N.W.","registrant_address_2":"Suite 900","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":80656,"url":"https://lda.gov/api/v1/registrants/80656/","house_registrant_id":36285,"name":"AMERICAN SOCIETY OF NEPHROLOGY","description":"Professional Medical Society - professional education","address_1":"1401 H Street, N.W.","address_2":"Suite 900","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RACHEL N. MEYER","contact_telephone":"+1 505-720-2009","dt_updated":"2026-07-16T12:59:08.586527-04:00"},"client":{"id":170996,"url":"https://lda.gov/api/v1/clients/170996/","client_id":12,"name":"AMERICAN SOCIETY OF NEPHROLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67147,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55611,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"NELL","last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145666,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"AHEARN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67147,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":"Senior Manager of Policy and Government Affairs","new":false},{"lobbyist":{"id":55611,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"NELL","last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e1da7f20-469c-41a2-8dad-a66311ab99a9/","filing_uuid":"e1da7f20-469c-41a2-8dad-a66311ab99a9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e1da7f20-469c-41a2-8dad-a66311ab99a9/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Deborah Darcy","dt_posted":"2026-07-20T16:49:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11921 Rockville Pike","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401103906,"url":"https://lda.gov/api/v1/registrants/401103906/","house_registrant_id":null,"name":"AMERICAN KIDNEY FUND","description":"Not-for-profit, charitable organization.","address_1":"11921 Rockville Pike","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DEBORAH DARCY","contact_telephone":"+1 202-560-4883","dt_updated":"2026-07-28T11:53:15.293997-04:00"},"client":{"id":200362,"url":"https://lda.gov/api/v1/clients/200362/","client_id":12,"name":"AMERICAN KIDNEY FUND","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-11-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Request for Information: Opportunities, Challenges, and Emerging Areas in Statistical Data, Analysis, and Research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63250,"prefix":null,"prefix_display":null,"first_name":"DEBORAH","nickname":null,"middle_name":null,"last_name":"DARCY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69036,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"A.","last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d16ec465-31ee-488f-9535-2d7bc8d27faf/","filing_uuid":"d16ec465-31ee-488f-9535-2d7bc8d27faf","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d16ec465-31ee-488f-9535-2d7bc8d27faf/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Deborah Darcy","dt_posted":"2026-10-20T11:42:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11921 Rockville Pike","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401103906,"url":"https://lda.gov/api/v1/registrants/401103906/","house_registrant_id":null,"name":"AMERICAN KIDNEY FUND","description":"Not-for-profit, charitable organization.","address_1":"11921 Rockville Pike","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DEBORAH DARCY","contact_telephone":"+1 202-560-4883","dt_updated":"2026-07-28T11:53:15.293997-04:00"},"client":{"id":200362,"url":"https://lda.gov/api/v1/clients/200362/","client_id":12,"name":"AMERICAN KIDNEY FUND","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-11-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 CMS-1846-P: Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program Medicaid Program; Community Engagement Requirement for Certain Individuals (CMS- 2454-IFC); Interim Final Rule with Comment Period","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63250,"prefix":null,"prefix_display":null,"first_name":"DEBORAH","nickname":null,"middle_name":null,"last_name":"DARCY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69036,"prefix":null,"prefix_display":null,"first_name":"HOLLY","nickname":null,"middle_name":"A.","last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149717,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"MOORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}